A covered call identified by MarketIntelligececenter.com's patented algorithm on United Therapeutics (UTHR) could yield about 4.42% (36.73% annualized, for comparison purposes only) in 44 days. Pair a long position in the stock with the …
United Therapeutics Corporation (NASDAQ:UTHR) stock surged on Friday as rumors of a takeover surged. The company is reportedly being considered as an acquisition by a major pharmaceutical giant, including Gilead Sciences Inc …
United Therapeutics Corp (NASDAQ: UTHR): Analysts expect the company to be under significant ... analysts believe that the stock will cool in 2015. The stock’s high valuation relative to peers, along with rate pressure and the company’s …
If you currently own United Therapeutics stock and would like to discuss your legal rights, please visit …
WDAM1mon
If you currently own United Therapeutics stock and would like to discuss your legal rights, please visit …
If you currently own United Therapeutics stock and would like to discuss your legal rights, please visit …
WBOC1mon
(AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported fourth-quarter earnings of $110.3 million. The Silver Spring, Maryland-based company said it had net income of $2.43 per share. Earnings, adjusted for stock option …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR